AS1011 — ACCUTAR-NA-01

AS1011 announces 1 IPv4 prefixes covering 1,024 addresses and 2 IPv6 prefixes.

About this network

The corporate network of Accutar Biotechnology, an AI-driven drug discovery company, carried under the handle ACCUTAR-NA-01 (its North American block).

What it's used for

• Enterprise connectivity for a clinical-stage biotech that pairs computational drug design with wet-lab validation.

Notable

• ARIN reassigned AS1011 to Accutar in 2022, so the low number is a recent allocation and carries no early-internet pedigree.
• The registrant of record is the company's Canadian entity, though Accutar itself is US-based, founded in 2015 with offices in Brooklyn, New York.

Interesting

• Accutar's platform has advanced its own candidates into FDA clinical trials, including an oral breast-cancer drug granted Fast Track designation.

This description is AI-generated, best-effort context — not authoritative, and provided without any guarantee of accuracy.

Announced prefixes

• 45.45.248.0/22
• 2602:fac8:100::/44
• 2602:fac8:140::/44

Upstream networks

• AS20119 Arrow Group Inc.
• AS46450 Pilot Fiber, Inc.
• AS6939 Hurricane Electric LLC
• AS398465 Rackdog, LLC
• AS9002 RETN Limited
• AS394256 Tech Futures Interactive Inc.
• AS24482 SG.GS
• AS7575 Australian Academic and Research Network (AARNet)
• AS3130 RGnet OU
• AS293 ESnet
• AS34927 iFog GmbH

Adjacent networks

• AS20119 Arrow Group Inc.
• AS46450 Pilot Fiber, Inc.
• AS6939 Hurricane Electric LLC
• AS398465 Rackdog, LLC
• AS9002 RETN Limited
• AS24482 SG.GS
• AS394256 Tech Futures Interactive Inc.
• AS293 ESnet
• AS3130 RGnet OU
• AS34927 iFog GmbH
• AS7575 Australian Academic and Research Network (AARNet)

Internet exchanges

• Seattle Internet Exchange — Seattle, United States
• YYCIX Calgary Internet Exchange — Calgary, Canada